These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38327891)
1. Performance of the walking trail making test in older adults with white matter hyperintensities. Zhao HY; Zhang ZQ; Huang YH; Li H; Wei FY World J Psychiatry; 2024 Jan; 14(1):102-110. PubMed ID: 38327891 [TBL] [Abstract][Full Text] [Related]
2. The association between white matter hyperintensity volume and gait performance under single and dual task conditions in older people with dementia: A cross-sectional study. Hairu R; Close JCT; Lord SR; Delbaere K; Wen W; Jiang J; Taylor ME Arch Gerontol Geriatr; 2021; 95():104427. PubMed ID: 34015687 [TBL] [Abstract][Full Text] [Related]
3. Depression Plays a Moderating Role in the Cognitive Decline Associated With Changes of Brain White Matter Hyperintensities. Park JH; Lee SB; Lee JJ; Yoon JC; Han JW; Kim TH; Jeong HG; Newhouse PA; Taylor WD; Kim JH; Woo JI; Kim KW J Clin Psychiatry; 2018 Sep; 79(5):. PubMed ID: 30192448 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychological impact of white matter hyperintensities in older adults without dementia. Chavda R; Cao JS; Benge JF Appl Neuropsychol Adult; 2021; 28(3):354-362. PubMed ID: 31287337 [TBL] [Abstract][Full Text] [Related]
5. The Walking Trail-Making Test is an early detection tool for mild cognitive impairment. Perrochon A; Kemoun G Clin Interv Aging; 2014; 9():111-9. PubMed ID: 24426778 [TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Breakdown is a Sensitive Biomarker of Cognitive and Language Impairment in Patients with White Matter Hyperintensities. Wang X; Shi Y; Chen Y; Gao Y; Wang T; Li Z; Wang Y Neurol Ther; 2023 Oct; 12(5):1745-1758. PubMed ID: 37490234 [TBL] [Abstract][Full Text] [Related]
7. Association between gait and cognition in an elderly population based sample. Valkanova V; Esser P; Demnitz N; Sexton CE; Zsoldos E; Mahmood A; Griffanti L; Kivimäki M; Singh-Manoux A; Dawes H; Ebmeier KP Gait Posture; 2018 Sep; 65():240-245. PubMed ID: 30558938 [TBL] [Abstract][Full Text] [Related]
8. White Matter Hyperintensities Related to Parkinson's Disease Executive Function. Linortner P; McDaniel C; Shahid M; Levine TF; Tian L; Cholerton B; Poston KL Mov Disord Clin Pract; 2020 Aug; 7(6):629-638. PubMed ID: 32775508 [TBL] [Abstract][Full Text] [Related]
9. Pathways linking regional hyperintensities in the brain and slower gait. Bolandzadeh N; Liu-Ambrose T; Aizenstein H; Harris T; Launer L; Yaffe K; Kritchevsky SB; Newman A; Rosano C Neuroimage; 2014 Oct; 99():7-13. PubMed ID: 24841418 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of a computerized cognitive stimulation program on older adults with mild cognitive impairment according to the severity of white matter hyperintensities. Djabelkhir-Jemmi L; Wu YH; Boubaya M; Marlats F; Lewis M; Vidal JS; Lenoir H; Charlieux B; Isabet B; Rigaud AS Clin Interv Aging; 2018; 13():1543-1554. PubMed ID: 30214174 [TBL] [Abstract][Full Text] [Related]
11. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P; J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647 [TBL] [Abstract][Full Text] [Related]
12. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment. Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518 [TBL] [Abstract][Full Text] [Related]
13. Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness. Gustavsson AM; Stomrud E; Abul-Kasim K; Minthon L; Nilsson PM; Hansson O; Nägga K Cerebrovasc Dis Extra; 2015; 5(2):41-51. PubMed ID: 26120319 [TBL] [Abstract][Full Text] [Related]
14. Painting by lesions: White matter hyperintensities disrupt functional networks and global cognition. Crockett RA; Hsu CL; Dao E; Tam R; Eng JJ; Handy TC; Liu-Ambrose T Neuroimage; 2021 Aug; 236():118089. PubMed ID: 33882347 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease]. Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351 [No Abstract] [Full Text] [Related]
16. The association between white matter hyperintensity volume and cognitive/physical decline in older people with dementia: A one-year longitudinal study. Hairu R; Close JCT; Lord SR; Delbaere K; Wen W; Jiang J; Taylor ME Aging Ment Health; 2022 Dec; 26(12):2503-2510. PubMed ID: 34569854 [TBL] [Abstract][Full Text] [Related]
17. Thalamocortical Functional Connectivity in Patients With White Matter Hyperintensities. Chen C; Wang X; Cao S; Zhang J; Wang Z; Pan W; Yang J; Tian Y; Qiu B; Wei Q; Wang K Front Aging Neurosci; 2021; 13():632237. PubMed ID: 33815090 [No Abstract] [Full Text] [Related]
18. Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study. Fruhwirth V; Enzinger C; Fandler-Höfler S; Kneihsl M; Eppinger S; Ropele S; Schmidt R; Gattringer T; Pinter D Eur J Neurol; 2021 Feb; 28(2):401-410. PubMed ID: 33065757 [TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment. Kumar D; Vipin A; Wong B; Ng KP; Kandiah N Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714 [No Abstract] [Full Text] [Related]
20. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]